Painless blood test could replace bone marrow biopsy for MPN patients
NCT ID NCT07648433
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to develop a new blood test that could replace the invasive bone marrow biopsy currently used to diagnose myeloproliferative neoplasms (MPNs), a group of blood cancers. Researchers will collect blood samples from 500 adults with suspected or confirmed MPN and analyze specific blood cells to see if they can accurately detect the disease. If successful, this test could make diagnosis faster, less painful, and more accessible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test that replaces painful bone marrow biopsies for diagnosing certain blood cancers.
- What could go wrong
- This is an early observational study, not a treatment trial. The test may not be accurate enough to replace biopsies, and results may take years to confirm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOPROLIFERATIVE NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug reduce bloodletting for polycythemia vera?
- Could a walk a day keep brain fog away after a stem cell transplant?
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Can a modified interferon rein in early myelofibrosis?
- Can pressurized oxygen boost cord blood transplants?
- New transplant recipe aims to tame Graft-Versus-Host disease